Showing results (41-50 of 10,913) with videos related to
Sort By:
Pageof 1,092
Clinical Breast Cancer|September 1, 2006
A phase I study of cetuximab/paclitaxel in patients with advanced-stage breast cancerShanu Modi, Gabriella D'Andrea, Larry Norton, et al.Drugs & Aging|August 3, 2005
Change in cycle 1 to cycle 2 haematological counts predicts toxicity in older patients with breast cancer receiving adjuvant chemotherapyArti Hurria, Kelly Brogan, Katherine S Panageas, et al.Drugs & Aging|September 15, 2005
Effect of creatinine clearance on patterns of toxicity in older patients receiving adjuvant chemotherapy for breast cancerArti Hurria, Anju Hurria, Kelly Brogan, et al.The Breast Journal|December 23, 2014
The development of dose-dense adjuvant chemotherapyClifford Hudis, Chau DangCancer Cell|July 4, 2009
Latent bone metastasis in breast cancer tied to Src-dependent survival signalsXiang H-F Zhang, Qiongqing Wang, William Gerald, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2008
Phase I study of a novel capecitabine schedule based on the Norton-Simon mathematical model in patients with metastatic breast cancerTiffany A Traina, Maria Theodoulou, Kimberly Feigin, et al.Journal of Clinical Pathology|January 6, 2006
Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor kappaB ligand (RANKL) in human breast tumoursC Van Poznak, S S Cross, M Saggese, et al.The Oncologist|February 1, 2011
Triple-negative breast cancer: an unmet medical needClifford A Hudis, Luca GianniCancer Control : Journal of the Moffitt Cancer Center|January 7, 2003
Aromatase inhibitors in breast cancer: an updateDiana E Lake, Clifford HudisSurgical Oncology Clinics of North America|October 6, 1997
Systemic treatment for stage I and stage II breast cancerC A Hudis, P BorgenPageof 1,092